CDKN2A and neoplasm: NGS analysis of the tumor biopsies confirmed the presence of CRISPR-induced edits in PTEN and CDKN2A in Oncopigs 2 and 3 (Fig. 4C,D; Fig. S6), indicating successful development of genetically tailored HCC in Oncopigs.